Biosensis

What Biosensis does

Biosensis is a neuroscience-focused life science reagent manufacturer founded in 2006 that develops and commercializes ELISA kits, primary and secondary antibodies (monoclonal, polyclonal, phosphospecific, recombinant chimeric), fluorescent dyes and axonal tracers, IHC reagents, IVD kits and components, proteins and peptides, superparamagnetic iron oxide nanoparticles, and adenovirus products. Its scientific positioning is anchored in nearly 30 years of expertise in neurotrophins and neurotrophin receptors, and over 400 peer-reviewed publications supporting its products, with particular focus on neurodegenerative disease research (Alzheimer's, Parkinson's, ALS), neurodevelopment, and neuro-metabolism. The company also offers contract services for custom antibody development, ELISA/immunoassay development, and adenovirus production under the RAPAd technology platform.

Biosensis generates revenue through one-time purchase sales of research reagents and contract services to academic researchers and industry/pharmaceutical R&D teams, priced via a quote-based model that is not publicly disclosed. The company operates a horizontal segmentation strategy serving both academic and industrial buyer personas, and goes to market through direct e-commerce on the Antibodies Inc. storefront, regional distributors worldwide, conference marketing (e.g., ADLM), monthly email newsletters, and an extensive library of scientific protocols, antibody education content, and signaling pathway resources.

Since 2024, Biosensis has operated as a wholly-owned branded subsidiary of Antibodies Inc., a 50+ year private life science tools parent whose broader portfolio includes NeuroMab, Aves Labs, PhosphoSolutions, and ImmunoChemistry Technologies. The integration provides shared distribution, e-commerce infrastructure, and cross-brand cross-sell reach across global academic and industrial research markets, but the input does not disclose revenue, headcount, parent segment reporting, or pricing for Biosensis as a standalone business.

Name

Biosensis

Legal name

Biosensis

Website

https://biosensis.com

Company type

Private

Founded year

2006

Operating status

Acquired

Headcount range

11–50 employees

Short description

Biosensis is a neuroscience research reagent manufacturer (acquired by Antibodies Inc. in 2024) producing ELISA kits, antibodies, and fluorescent dyes for academic and pharmaceutical researchers investigating neurodegenerative diseases, neurodevelopment, and neuro-metabolism globally.

Ownership category

akta.pro rank

Headquarters

HQ city

Thebarton

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Research Reagent Sales: Sale of ELISA kits, antibodies, and dyes/tracing reagents to neuroscience researchers in academia and industry

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Biosensis manufactures and sells neuroscience-focused research reagents, including ELISA Kits, primary and secondary antibodies (monoclonal, polyclonal, phosphospecific, recombinant chimeric), antibody kits, fluorescent dyes and tracing reagents, cell viability/metabolism assay kits, IHC reagents, IVD kits, proteins/peptides, superparamagnetic iron oxide nanoparticles, and adenovirus products. The company also offers contract services for custom antibody development, ELISA/immunoassay development, and adenovirus production.

Product overview

Biosensis, now part of Antibodies Inc., offers a comprehensive portfolio of laboratory reagents and services for neuroscience and biomedical research. The product portfolio centers on ELISA Kits (including development kits and paired ELISA formats), antibodies (primary, secondary, monoclonal, polyclonal, phosphospecific, and recombinant chimeric), and specialized assay reagents including Cell Viability/Metabolism Assays (apoptosis, autophagy, caspases, oxidative stress), IHC Reagents, Dyes & Tracing Reagents, IVD Kits, Proteins/Peptides, Nanoparticles, and Adenovirus Products. The company also provides contract services for Custom Antibody Development (polyclonal, monoclonal, phosphospecific, and recombinant formats), ELISA/ImmunoAssay development, and Adenovirus Production. These products collectively support research in neurodegenerative diseases (Alzheimer's, Parkinson's, ALS), neurodevelopment, autophagy, and metabolic disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• ELISA Kits Enzyme-linked immunosorbent assay kits for quantitative detection of proteins and biomarkers in research and diagnostic applications, used by neuroscience and biomedical researchers.
• ELISA Development Kits Kits for developing and optimizing custom ELISA assays with components including plates, reagents, and protocols.
• Primary Antibodies Monoclonal, polyclonal, phosphospecific, and recombinant chimeric antibodies for research applications including Western blot, IHC, and ELISA.
• Secondary Antibodies Conjugated and unconjugated secondary antibodies for detection of primary antibodies in various immunoassay formats.
• Antibody Kits Pre-configured kits including antibody labeling kits, sampler kits, immunocytochemistry kits, and paired ELISA kits.
• Dyes & Tracing Reagents Fluorescent dyes, axonal tracers, ion indicators, and staining reagents for neuroscience and cellular imaging research.
• Cell Viability, Metabolism Assays, and Biochemicals Assay kits for apoptosis, autophagy, caspases, cathepsins, cytotoxicity, mitochondrial function, oxidative stress, and pyroptosis detection.
• IHC Reagents Immunohistochemistry reagents including antigen retrievers, blocking reagents, buffers, chromogens, counter stains, and mounting media.
• IVD Kits and Components In vitro diagnostic kits and components for clinical laboratory applications.
• Proteins, Peptides and Small Molecules Research-grade proteins, peptides, and small molecules for laboratory applications and assay development.
• Superparamagnetic Iron Oxide Nanoparticles Superparamagnetic iron oxide nanoparticles for cellular imaging, drug delivery, and biomedical research applications.
• Adenovirus Products Adenovirus vectors, constructs, and control products for gene delivery and expression research.
• Custom Antibody Development Contract services including polyclonal chicken IgY production, mouse monoclonal development, phosphospecific antibody development, recombinant antibody development, and hybridoma scale-up.
• ELISA / ImmunoAssay Services Contract services for ELISA development, optimization, and validation.
• Adenovirus Production Services Contract manufacturing services for adenovirus amplification, purification, and quality control using RAPAd technology.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Novus Biologicals (Bio-Techne): Research antibody and reagent vendor covering wide neuroscience targets; competes with Biosensis for primary antibody purchases from academic and pharma researchers.
• Abcam: Global leader in research-grade antibodies, ELISA kits, and reagents for life science research; directly competes with Biosensis' catalog across neuroscience and adjacent targets, with a much broader catalog.
• R&D Systems (Bio-Techne): Major supplier of ELISA kits, antibodies, and proteins for life science research, including neurotrophins — directly competes with Biosensis' ELISA and antibody catalog in academia and pharma.
• Santa Cruz Biotechnology: Long-standing catalog supplier of monoclonal, polyclonal, and conjugated antibodies and ELISA reagents to academic and industry researchers; competes on breadth and price in the same reagent category as Biosensis.
• Cell Signaling Technology: Specialist in phosphospecific and signaling-pathway antibodies and ELISA kits for academic and pharma researchers, including neuroscience applications; highly comparable product portfolio and customer base to Biosensis.

Emerging players

• GenScript: Custom antibody development, recombinant antibody and protein services provider with a growing catalog; directly competes with Biosensis' Custom Antibody Development service line and increasingly with catalog reagents.
• Proteintech: Rapidly growing antibody manufacturer emphasizing knockout/knockdown validation; competes for neuroscience antibody purchases from academic and pharma customers on the strength of validation — Biosensis' core differentiator.
• Rockland Immunochemicals: Mid-sized specialty antibody and immunoassay reagent provider offering custom and catalog antibodies plus ELISA services; comparable niche position with a strong focus on validation and custom services similar to Biosensis.

Broad incumbents

• Merck Millipore Sigma: Broad life science reagents and tools catalog covering antibodies, ELISA kits, IHC, dyes, and biochemicals for neuroscience and general research; serves the same customer base but at much larger scale.
• Thermo Fisher Scientific (Pierce Antibodies / Invitrogen): Diversified life science tools giant offering research antibodies, ELISA kits, IHC reagents, dyes, and IVD components through Pierce/Invitrogen brands; overlaps with Biosensis but as part of a much broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/biosensis
• LinkedInlinkedin.com/company/biosensis-pty-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biosensis